Carelwon

6234993

Carelwon® is a tincture extract. Application areas span six core inflamaging disease targets — NF-κB, IL-6, TNF, IgG, IgM, and Nitric Oxide — reflecting Carelwon®'s multi-target anti-inflammatory action across these inflammatory pathways. Carelwon®'s multi-target action outperforms standard ginger, curcumin, and berberine by up to 105×, and outperforms CBD by 13× in the gold-standard preclinical arthritis model — positioning Carelwon® as the leading multi-pathway solution in the chronic inflammation and inflammaging space. Primary focus areas include longevity and healthy ageing, joint health and mobility, cardiovascular and metabolic health, cognitive health, gut and digestive health, and general immune and inflammatory support.

Anti-Allergens; Bone & Joint Health; Cardiovascular Health; Cognitive & Mental Function; Digestive Health; Energy & Endurance; Ethical Sourcing; Green Product; Immune Health; International Approvals/Standards; Natural Ingredients; Sustainability; Weight Loss Management; Up to 105× more potent than standard ginger, curcumin, and berberine across six inflammatory pathways 13× stronger than CBD in the gold-standard preclinical arthritis model Multi-target action (NF-κB, IL-6, TNF, IgG, IgM, Nitric Oxide) vs. single-compound competitors. Phase 1 safety and tolerability confirmed (MRINZ, n=50) Patent families filed across 53 countries, covering 100+ disease indications Composition of matter, formulation, and manufacturing all protected Global longevity market: USD $65B, growing at 25% CAGR to $314B by 2030 Targets inflammaging — chronic inflammation affecting an estimated 1 in 5 people First commercial batch sold out in three days with zero advertising. Bulk sales. Unsolicited adoption by Hurricanes CEO Tony Philp DTC Shopify subscription model already live Speaking invitation to CPhI Milan 2026 (62,000 visitors) Founder-led with 22+ years of clinical research and herbal medicine experience, plus an MBA Deep personal founding story. 

Tincture

New Zealand

litre; milligram